TY  - GEN
AU  - Lebranchu,Yvon
AU  - Bridoux,Frank
AU  - Büchler,Matthias
AU  - Le Meur,Yannick
AU  - Etienne,Isabelle
AU  - Toupance,Olivier
AU  - Hurault de Ligny,Bruno
AU  - Touchard,Guy
AU  - Moulin,Bruno
AU  - Le Pogamp,Patrick
AU  - Reigneau,Olivier
AU  - Guignard,Michel
AU  - Rifle,Gérard
TI  - Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy
SN  - 1600-6135
PY  - 2002///1223
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antilymphocyte Serum
KW  - Basiliximab
KW  - Creatinine
KW  - blood
KW  - Cyclosporine
KW  - pharmacokinetics
KW  - Drug Therapy, Combination
KW  - Female
KW  - France
KW  - Graft Rejection
KW  - epidemiology
KW  - Humans
KW  - Immunosuppression Therapy
KW  - methods
KW  - Kidney Failure, Chronic
KW  - etiology
KW  - Kidney Transplantation
KW  - immunology
KW  - Male
KW  - Middle Aged
KW  - Mycophenolic Acid
KW  - analogs & derivatives
KW  - Racial Groups
KW  - Recombinant Fusion Proteins
KW  - Safety
KW  - Time Factors
KW  - Tissue Donors
KW  - statistics & numerical data
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1034/j.1600-6143.2002.020109.x
ER  -